153 related articles for article (PubMed ID: 34783208)
1. Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study.
Shim SH; Lim MC; Lee D; Won YJ; Ha HI; Chang HK; Cho H
J Gynecol Oncol; 2022 Jan; 33(1):e5. PubMed ID: 34783208
[TBL] [Abstract][Full Text] [Related]
2. Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area.
Kim BH; Lee D; Jung KW; Won YJ; Cho H
Clin Mol Hepatol; 2022 Apr; 28(2):242-253. PubMed ID: 35130416
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
[TBL] [Abstract][Full Text] [Related]
4. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
[TBL] [Abstract][Full Text] [Related]
5. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
[TBL] [Abstract][Full Text] [Related]
6. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.
Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK
Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502
[TBL] [Abstract][Full Text] [Related]
7. Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
Li J; Zheng Q; Zhao X; Zhao J; An T; Wu M; Wang Y; Zhuo M; Zhong J; Yang X; Jia B; Chen H; Dong Z; Wang J; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Aug; 20(1):793. PubMed ID: 32838776
[TBL] [Abstract][Full Text] [Related]
8. Impact of nonspecific death on overall survival in early-stage epithelial ovarian cancer patients.
Dai D; Deng T; Wang B; Chen S; Liu Z; Luo X; Wang F; Huang H; Liu J
Curr Probl Cancer; 2021 Feb; 45(1):100621. PubMed ID: 32732013
[TBL] [Abstract][Full Text] [Related]
9. Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study.
Hermens M; van Altena AM; Nieboer TE; Schoot BC; van Vliet HAAM; Siebers AG; Bekkers RLM
Am J Obstet Gynecol; 2020 Jul; 223(1):107.e1-107.e11. PubMed ID: 31981507
[TBL] [Abstract][Full Text] [Related]
10. Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up.
Bouchard-Fortier G; Panzarella T; Rosen B; Chapman W; Gien LT
J Obstet Gynaecol Can; 2017 Jan; 39(1):34-41. PubMed ID: 28062021
[TBL] [Abstract][Full Text] [Related]
11. Non-aspirin NSAID use and ovarian cancer mortality.
Verdoodt F; Dehlendorff C; Friis S; Kjaer SK
Gynecol Oncol; 2018 Aug; 150(2):331-337. PubMed ID: 29960709
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
14. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
[TBL] [Abstract][Full Text] [Related]
15. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study.
Tetsche MS; Dethlefsen C; Pedersen L; Sorensen HT; Norgaard M
BMC Cancer; 2008 Jan; 8():31. PubMed ID: 18230177
[TBL] [Abstract][Full Text] [Related]
16. Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: a competing risk analysis.
Chang YH; Li WH; Chang Y; Peng CW; Cheng CH; Chang WP; Chuang CM
BMC Cancer; 2016 Mar; 16():235. PubMed ID: 26988703
[TBL] [Abstract][Full Text] [Related]
17. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada.
Arora N; Talhouk A; McAlpine JN; Law MR; Hanley GE
Int J Gynecol Cancer; 2019 Mar; 29(3):593-598. PubMed ID: 30821698
[TBL] [Abstract][Full Text] [Related]
18. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
[TBL] [Abstract][Full Text] [Related]
19. Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada.
Arora N; Talhouk A; McAlpine JN; Law MR; Hanley GE
BMC Cancer; 2018 Oct; 18(1):1039. PubMed ID: 30359249
[TBL] [Abstract][Full Text] [Related]
20. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
